-
Study: SAMe may benefit patients taking antidepressants
BOSTON A new study conducted by investigators at Harvard Medical School and Massachusetts General Hospital suggested that the dietary supplement S-adenosylmethionine (SAMe) can be an effective, relatively well-tolerated, adjunctive treatment for adults with major depressive disorders who do not respond to their treatment with antidepressant medication, Pharmavite announced Tuesday.
-
Cutler: 'Saving money while improving quality of care' should be at forefront
SAN DIEGO Comparing the situation with a hypothetical B-movie about a whale eating New York, Harvard University economics professor David Cutler showed a chart describing the fiscal collision course the United States could be on if it doesn’t successfully tackle healthcare costs.